![Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529) – ScienceOpen Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529) – ScienceOpen](https://www.scienceopen.com/document_file/47777c21-a8ae-48b6-af6a-42b09dac5c80/ScienceOpen/image/zoonoses20210024_fig1.jpg)
Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529) – ScienceOpen
![An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies | Nature Medicine An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-021-01678-y/MediaObjects/41591_2021_1678_Fig1_HTML.png)
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies | Nature Medicine
![Vinod Scaria on Twitter: "What do we know about the B.1.1.529 variant of SARS-CoV-2 with a very large number of mutations An updated thread on emerging evidence. https://t.co/D8nzB6ssgg" / Twitter Vinod Scaria on Twitter: "What do we know about the B.1.1.529 variant of SARS-CoV-2 with a very large number of mutations An updated thread on emerging evidence. https://t.co/D8nzB6ssgg" / Twitter](https://pbs.twimg.com/media/FFDlYGhUYAEZrZi.png)
Vinod Scaria on Twitter: "What do we know about the B.1.1.529 variant of SARS-CoV-2 with a very large number of mutations An updated thread on emerging evidence. https://t.co/D8nzB6ssgg" / Twitter
![Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study - The Lancet Infectious Diseases Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/6580e83f-8fd8-42dc-8e38-997b6c0cf7b8/gr1_lrg.jpg)
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study - The Lancet Infectious Diseases
![Dr Emma Hodcroft on Twitter: "You can also see 21K (B.1.1.529) on the Shared Mutations page (& too big to screenshot!) to compare what Spike mutations we also see in other variants. Dr Emma Hodcroft on Twitter: "You can also see 21K (B.1.1.529) on the Shared Mutations page (& too big to screenshot!) to compare what Spike mutations we also see in other variants.](https://pbs.twimg.com/media/FFH2k-5XEAEd7YB.jpg)
Dr Emma Hodcroft on Twitter: "You can also see 21K (B.1.1.529) on the Shared Mutations page (& too big to screenshot!) to compare what Spike mutations we also see in other variants.
![Emerging evidence on Omicron (B.1.1.529) SARS‐CoV‐2 variant - Sharma - 2022 - Journal of Medical Virology - Wiley Online Library Emerging evidence on Omicron (B.1.1.529) SARS‐CoV‐2 variant - Sharma - 2022 - Journal of Medical Virology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/395c5dce-9ec8-40e1-96bf-496403725325/jmv27626-fig-0005-m.jpg)
Emerging evidence on Omicron (B.1.1.529) SARS‐CoV‐2 variant - Sharma - 2022 - Journal of Medical Virology - Wiley Online Library
![Africa Centres for Disease Control and Prevention's Statement regarding the new SARS-COV-2 virus variant B.1.1.529 – Africa CDC Africa Centres for Disease Control and Prevention's Statement regarding the new SARS-COV-2 virus variant B.1.1.529 – Africa CDC](https://africacdc.org/wp-content/uploads/2021/11/coronavirus-africa-cdc.jpg)
Africa Centres for Disease Control and Prevention's Statement regarding the new SARS-COV-2 virus variant B.1.1.529 – Africa CDC
![Vinod Scaria on Twitter: "The B.1.1.529 variants seemed to be spreading rapidly in South Africa, much faster than other VoCs we have seen in the past. https://t.co/UnjsHux9Gm" / Twitter Vinod Scaria on Twitter: "The B.1.1.529 variants seemed to be spreading rapidly in South Africa, much faster than other VoCs we have seen in the past. https://t.co/UnjsHux9Gm" / Twitter](https://pbs.twimg.com/media/FFGheDAUcAAPRTC.png)
Vinod Scaria on Twitter: "The B.1.1.529 variants seemed to be spreading rapidly in South Africa, much faster than other VoCs we have seen in the past. https://t.co/UnjsHux9Gm" / Twitter
![Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein - Kumar - 2022 - Journal of Medical Virology - Wiley Online Library Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein - Kumar - 2022 - Journal of Medical Virology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d8f68879-5411-425c-815d-4619897e2e40/jmv27526-fig-0001-m.jpg)
Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein - Kumar - 2022 - Journal of Medical Virology - Wiley Online Library
![Viruses | Free Full-Text | A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies Viruses | Free Full-Text | A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies](https://pub.mdpi-res.com/viruses/viruses-15-00167/article_deploy/html/images/viruses-15-00167-g001.png?1673587163)
Viruses | Free Full-Text | A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
![Frontiers | Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions Frontiers | Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions](https://www.frontiersin.org/files/Articles/830202/fviro-02-830202-HTML/image_m/fviro-02-830202-g001.jpg)
Frontiers | Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions
![What do we know about the new B.1.1.529 coronavirus variant and should we be worried? | Gavi, the Vaccine Alliance What do we know about the new B.1.1.529 coronavirus variant and should we be worried? | Gavi, the Vaccine Alliance](https://www.gavi.org/sites/default/files/vaccineswork/2021/Thumb/shutterstock_1924081337_h2.jpg)
What do we know about the new B.1.1.529 coronavirus variant and should we be worried? | Gavi, the Vaccine Alliance
![Mia Malan on Twitter: "[Thread] What is the potential impact of the new B. 1.1.529 #COVID19 variant? @rjlessells: 1. It's relatively simple to detect some B.1.1.529 cases, as it's possible to use PCR Mia Malan on Twitter: "[Thread] What is the potential impact of the new B. 1.1.529 #COVID19 variant? @rjlessells: 1. It's relatively simple to detect some B.1.1.529 cases, as it's possible to use PCR](https://pbs.twimg.com/media/FFCWwQDXEAErpCL.jpg)